Velora brings together various essential service areas under one platform to deliver end-to-end aviation solutions ...

David S. Hage, James Hewett University Professor at the University of Nebraska–Lincoln, discusses how advances in affinity-based separations are shaping the future of personalized medicine and ...

Building on EAS’ long-standing legacy, Velora will continue to support Abu Dhabi’s airports while strengthening the Emirate’s ...

Q3 2025 Earnings Call Transcript November 6, 2025 Esperion Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.15812 EPS, expectations were $-0.09. Operator: Hello, ladies and ...

Taking only those written in the last week, the most popular stories on our website cover acetonitrile electrolyte battery technology, Du Pont spinning off its semiconductor industry support business, ...

Under its new identity, Velora oversees daily operations across multiple business divisions, supported by a diverse and highly skilled workforce ...

Etihad Airport Services (EAS) has announced that it is rebranding to Velora, marking a major milestone in the evolution of ...

Etihad Airport Services (EAS), which Ground Handling, Cargo & Logistics, and Security Services has rebranded under a single ...

Njoroge Kibugu of Windsor Golf Club headlines a strong field of 88 golfers who have signed up for the 8th leg of the Sunshine ...

Welcome to the Eyes on Washington: Shutdown Briefing. During the federal government shutdown, we will be sharing concise, client-focused updates to help you stay informed on key developments, ...

Q3 2025 U.S. Net Product Revenue Grew 31% Y/Y to $40.7 Million – – Reached Settlement Agreement with ANDA Filer, Dr. Reddy’s Laboratories, Not to Market Generic Versions of NEXLETOL® (bempedoic acid) ...

Esperion Therapeutics Inc (ESPR) reports significant revenue growth and strategic agreements, setting the stage for sustained profitability and market expansion.